John Crean

John Crean has a diverse work experience in the pharmaceutical industry. Their most recent role was as the Regional Medical Director at Xeris Pharmaceuticals, Inc. starting in June 2022. Prior to that, they served as the Associate Scientific Director for Global Medical Affairs at Zealand Pharma from November 2020 to June 2022. Before joining Zealand Pharma, John worked as a Senior Medical Science Liaison at Amarin Corporation from June 2019 to November 2020. John also held positions at The Janssen Pharmaceutical Companies of Johnson & Johnson as a Principal Medical Science Liaison for Diabetes from April 2013 to June 2019, at Eisai as a Senior Medical Science Liaison for Metabolism from August 2012 to April 2013, at Bristol Myers Squibb as a Senior MSL for Diabetes from 2008 to August 2012, and at Amylin as a Senior MSL for Diabetes from 2003 to 2008.

John Crean completed their Bachelor of Science degree in Psychology from the University of Vermont from 1989 to 1993. John later pursued a PhD in Clinical Psychology/ Psychopharmacology at the Illinois Institute of Technology, which they completed from 1995 to 2001. Additionally, John Crean received a Master of Science in Law (MSL), although the specific details regarding the start and end years and the field of study are not provided.